Cardiovascular safety of liraglutide assessed in a patient-level pooled analysis of phase 2—3 liraglutide clinical development studies
Year: 2011
Type: article
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: AstraZeneca, Medicines Company, Novo Nordisk
OpenAlex ID: W2140682563
